OneVentures

OneVentures OneVentures is one of Australia's leading VCs, managing AU$900M across 7 funds since 2010. The firm runs a dual focus: Technology (growth equity and credit) and Healthcare (therapeutics, devices, diagnostics). Fund III specifically targets Australian healthcare companies at or near clinical development. Like Brandon Capital, OneVentures is a licensed manager for the Australian Government's $500M Biomedical Translation Fund. The portfolio includes Vaxxas (needle-free drug delivery) an